| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA778: Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuria |
|
Medicine details |
|
| Medicine name | pegcetacoplan (Aspaveli®) |
| Formulation | subcutaneous injection |
| Reference number | 4186 |
| Indication | Treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who are anaemic after treatment with a C5 inhibitor for at least 3 months |
| Company | Swedish Orphan Biovitrum Ltd |
| BNF chapter | Nutrition & blood |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 09/12/2021 |
| NICE guidance | TA778: Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuria |